FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment On July 29, 2024, the US FDA approved Alpha Cognition Inc.’s ALPHA-1062 (Zunveyl).®), an Acetylcholinesterase (AChE) inhibitor, for the treatment…
